Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19.
作者信息
Carlet Jean, Payen Didier, Opal Steven M
机构信息
World Alliance Against Antibiotic Resistance, 94000 Créteil, France.
Paris 7 University, Paris, France.
出版信息
Lancet. 2020 Oct 24;396(10259):e61-e62. doi: 10.1016/S0140-6736(20)32132-2. Epub 2020 Oct 9.
Abstract
摘要
相似文献
1
Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19.用于脓毒症和急性呼吸窘迫综合征的类固醇：在新型冠状病毒肺炎中，这一长期存在的争议依然存在。
Lancet. 2020 Oct 24;396(10259):e61-e62. doi: 10.1016/S0140-6736(20)32132-2. Epub 2020 Oct 9.
2
Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.间充质基质细胞治疗急性呼吸窘迫综合征（ARDS）、脓毒症和 COVID-19 感染：优化治疗潜力。
Expert Rev Respir Med. 2021 Mar;15(3):301-324. doi: 10.1080/17476348.2021.1848555. Epub 2020 Nov 26.
3
COVID-19 and non-COVID ARDS patients demonstrate a distinct response to low dose steroids- A retrospective observational study.COVID-19 和非 COVID-19 导致的急性呼吸窘迫综合征患者对低剂量类固醇的反应明显不同——一项回顾性观察研究。
J Crit Care. 2021 Apr;62:46-48. doi: 10.1016/j.jcrc.2020.11.012. Epub 2020 Nov 21.
4
Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?用烯丙哌三嗪治疗低氧血症型新冠肺炎“急性呼吸窘迫综合征”患者：越早越好？
Anaesth Crit Care Pain Med. 2020 Aug;39(4):451-452. doi: 10.1016/j.accpm.2020.07.003. Epub 2020 Jul 9.
5
Metformin in acute respiratory distress syndrome: An opinion.二甲双胍在急性呼吸窘迫综合征中的应用：一种观点。
Exp Gerontol. 2021 Mar;145:111197. doi: 10.1016/j.exger.2020.111197. Epub 2020 Dec 10.
6
Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS).氨苯砜、秋水仙碱和奥氮平作为辅助治疗药物预防新型冠状病毒肺炎相关的成人呼吸窘迫综合征（ARDS）。
Med Hypotheses. 2020 Aug;141:109774. doi: 10.1016/j.mehy.2020.109774. Epub 2020 Apr 23.
7
Respiratory characteristics and related intraoperative ventilatory management for patients with COVID-19 pneumonia.新型冠状病毒肺炎患者的呼吸特征及相关术中通气管理。
J Anesth. 2021 Jun;35(3):356-360. doi: 10.1007/s00540-020-02845-0. Epub 2020 Aug 31.
8
Using the lung ultrasound score to monitor disease progression for COVID-19-associated ARDS.使用肺部超声评分监测新型冠状病毒肺炎相关急性呼吸窘迫综合征的疾病进展。
Intensive Care Med. 2021 Nov;47(11):1329-1331. doi: 10.1007/s00134-021-06515-x. Epub 2021 Sep 30.
9
Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.Δ9-四氢大麻酚通过诱导免疫细胞凋亡，从而抑制细胞因子风暴，防止急性呼吸窘迫综合征导致的死亡。
Int J Mol Sci. 2020 Aug 28;21(17):6244. doi: 10.3390/ijms21176244.
10
Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.基于 COVID-19、其他冠状病毒感染、流感、社区获得性肺炎和急性呼吸窘迫综合征的证据评估 COVID-19 中皮质类固醇的疗效和安全性：系统评价和荟萃分析。
CMAJ. 2020 Jul 6;192(27):E756-E767. doi: 10.1503/cmaj.200645. Epub 2020 May 14.
引用本文的文献
1
A critical assessment of corticosteroid trials for hospitalised patients with SARS-CoV-2 disease.对SARS-CoV-2疾病住院患者进行的皮质类固醇试验的批判性评估。
Intensive Care Med. 2025 May;51(5):972-974. doi: 10.1007/s00134-025-07878-1. Epub 2025 May 23.
2
Risk factors for acute respiratory distress syndrome in sepsis patients: A meta-analysis.脓毒症患者急性呼吸窘迫综合征的危险因素：一项荟萃分析。
Heliyon. 2024 Sep 2;10(18):e37336. doi: 10.1016/j.heliyon.2024.e37336. eCollection 2024 Sep 30.
3
Genetic Determinants of the Acute Respiratory Distress Syndrome.急性呼吸窘迫综合征的遗传决定因素
J Clin Med. 2023 May 27;12(11):3713. doi: 10.3390/jcm12113713.
4
Polymorphism in interferon alpha/beta receptor contributes to glucocorticoid response and outcome of ARDS and COVID-19.干扰素 α/β 受体多态性与 ARDS 和 COVID-19 的糖皮质激素反应和结局有关。
Crit Care. 2023 Mar 16;27(1):112. doi: 10.1186/s13054-023-04388-8.
5
Applying Lessons Learned From COVID-19 Therapeutic Trials to Improve Future ALI/ARDS Trials.借鉴新冠病毒治疗试验的经验教训以改进未来的急性肺损伤/急性呼吸窘迫综合征试验。
Open Forum Infect Dis. 2022 Jul 30;9(8):ofac381. doi: 10.1093/ofid/ofac381. eCollection 2022 Aug.
6
Review: the role of GSDMD in sepsis.综述：GSDMD 在脓毒症中的作用。
Inflamm Res. 2022 Nov;71(10-11):1191-1202. doi: 10.1007/s00011-022-01624-9. Epub 2022 Aug 15.
7
Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States.地塞米松治疗美国住院 COVID-19 患者的疗效比较。
Adv Ther. 2022 Oct;39(10):4723-4741. doi: 10.1007/s12325-022-02267-2. Epub 2022 Aug 12.
8
Differential Immune Checkpoint and Ig-like V-Type Receptor Profiles in COVID-19: Associations with Severity and Treatment.COVID-19中不同的免疫检查点和Ig样V型受体谱：与严重程度和治疗的关联
J Clin Med. 2022 Jun 8;11(12):3287. doi: 10.3390/jcm11123287.
9
Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease.针对登革热疾病的宿主导向治疗靶向 Annexin A1-FPR2/ALX 通路。
Elife. 2022 Mar 16;11:e73853. doi: 10.7554/eLife.73853.
10
Induction of CD73 prevents death after emergency open aortic surgery for a ruptured abdominal aortic aneurysm: a randomized, double-blind, placebo-controlled study.诱导 CD73 预防破裂性腹主动脉瘤急诊开放主动脉手术后死亡：一项随机、双盲、安慰剂对照研究。
Sci Rep. 2022 Feb 3;12(1):1839. doi: 10.1038/s41598-022-05771-1.
Zotero 插件